| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.93B | 3.86B | 3.22B | 3.38B | 2.83B | 2.10B |
| Gross Profit | 366.99M | 391.02M | 336.98M | 657.90M | 476.12M | 273.27M |
| EBITDA | -7.59M | 39.42M | 17.34M | 329.44M | 176.11M | 31.84M |
| Net Income | 15.34M | 12.75M | 2.72M | 274.63M | 130.71M | -5.17M |
Balance Sheet | ||||||
| Total Assets | 2.09B | 2.05B | 1.74B | 1.68B | 1.37B | 1.02B |
| Cash, Cash Equivalents and Short-Term Investments | 155.54M | 101.73M | 77.84M | 103.30M | 58.02M | 62.56M |
| Total Debt | 937.06M | 862.35M | 718.32M | 663.43M | 700.00M | 572.24M |
| Total Liabilities | 1.46B | 1.42B | 1.16B | 1.08B | 1.03B | 816.25M |
| Stockholders Equity | 595.70M | 585.78M | 581.42M | 602.62M | 339.08M | 205.50M |
Cash Flow | ||||||
| Free Cash Flow | -35.59M | -63.40M | -19.81M | -40.29M | -337.51M | -213.31M |
| Operating Cash Flow | 21.11M | 61.04M | 120.07M | 234.08M | -122.53M | -125.22M |
| Investing Cash Flow | -86.15M | -158.51M | -140.43M | -197.72M | -164.18M | -150.75M |
| Financing Cash Flow | 72.88M | 126.98M | -4.97M | 9.07M | 284.99M | 303.34M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | HK$1.21B | 16.88 | 3.61% | 1.85% | -8.51% | -68.34% | |
59 Neutral | HK$2.36B | 132.95 | 2.59% | ― | 11.08% | 147.89% | |
57 Neutral | HK$2.78B | 3.69 | 13.87% | ― | 9.20% | 213.87% | |
54 Neutral | HK$1.22B | 18.94 | 2.46% | 3.73% | -5.29% | -32.47% | |
41 Neutral | €153.61M | -1.89 | -13.04% | ― | -17.15% | 30.94% | |
40 Underperform | HK$162.76M | -0.27 | -112.79% | ― | -22.72% | -212.73% |
GHW International, a company incorporated in the Cayman Islands, reported its interim financial results for the six months ending June 30, 2025. The company experienced a 3.7% increase in revenue compared to the same period in 2024, reaching approximately RMB1,856.7 million. Despite a decrease in gross profit by 12.4%, the net profit rose by 77.1% to approximately RMB7.9 million. Basic earnings per share also increased by 40%. However, the Board decided not to recommend any interim dividend for this period.
The most recent analyst rating on (HK:9933) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on GHW International stock, see the HK:9933 Stock Forecast page.
GHW International has issued a supplemental and clarification announcement regarding its annual report for the year ended 31 December 2024. The company has clarified that the total number of shares available for grant under its Share Option Scheme as of 31 December 2024 is 100,000,000 shares, which represents approximately 9.91% of the total issued shares, correcting an earlier figure of 100,950,000 shares. This announcement does not affect any other information in the annual report.
The most recent analyst rating on (HK:9933) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on GHW International stock, see the HK:9933 Stock Forecast page.
GHW International has announced a positive profit alert, expecting a net profit of approximately RMB8 million for the first half of 2025, compared to RMB4.4 million in the same period of 2024. The increase in profit is attributed to gains from currency appreciation and a value-added tax credit refund, despite facing decreased gross profits from some products due to increased market competition.
The most recent analyst rating on (HK:9933) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on GHW International stock, see the HK:9933 Stock Forecast page.
GHW International has announced an upcoming board meeting scheduled for August 27, 2025, to discuss and approve the interim financial results for the first half of the year, as well as to consider the recommendation of an interim dividend. This meeting is significant as it will provide insights into the company’s financial health and potential returns for shareholders, impacting its operations and market positioning.